@promegauk.bsky.socialNew approach methodologies (NAMs) like organoids demand more from assays than traditional 2D methods can offer
Our colleague's Drug Target Review article explores six key requirements, including kinetic readouts, multiplexing and reproducibility - https://ow.ly/XV6I50ZSIki
@lucidscientific.bsky.socialThe FDA recently swapped "animal" for "nonclinical" in its safety testing rules.
Human models take weeks to build. Resipher measures their respiration the whole time, right in your incubator.
Published in iPSC models, organoids and spheroids: lucidsci.com/resources#pu... #NAMs
@dynamic42.bsky.socialLoad. Seal. Perfuse. 🧫 Meet the DynamicOrgan® Load&Seal Kit—an open-top biochip for integrating tissue slices, biomaterials and other large samples into perfused systems.
👉 Learn more here: zurl.co/ozwJR
#OrganOnChip #MPS #NAMs
@kellydobos.bsky.socialNAMs are generating more human relevant data while helping reduce reliance on animal testing in pharmaceutical research. If you're interested in where alternative testing methods and safety substantiation are headed, this article is well worth the read!
@stocktitan.net#NAMS NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
@jprecmed.bsky.social📢 Call for Papers📢
New Approach Methodologies (#NAMs) in Precision Medicine: Transforming Translational Research and Human Health
Submit your research by 31 December 2026 to publish #OpenAccess with no fees💡
@kellydobos.bsky.socialUS FDA Expects To Spur Options To Animal Testing By Inserting ‘Nonclinical’ In Regulatory Language
#BeautyIndustryNews #Businessofbeauty #NAMs #CosmeticScience #CosmeticSafety
@jprecmed.bsky.social'Digital twins in nuclear medicine: Science fiction or reality?' 🛸
Deni Hardiansyah and co-authors discuss the role of #DigitalTwins in #radiopharmaceutical therapy in this review, part of the #NAMs special issue 📖
Read the article👇️
doi.org/10.1016/j.pr...
@thecolaab.bsky.socialIf your research involves organoids, organs-on-chips, computational modeling, advanced cell and tissue systems, or other nonanimal approaches, consider signing up!
@keintierversuch.bsky.socialDie #DFG zählt mehr #NAMs wie #Organoide & Organ-on-a-Chip – doch 75,1 % der 2025 erfassten Projekte nutzten ausschließlich #Tierversuche. Dass NAMs und Tierversuche gemeinsam vorkommen, belegt keine „Komplementarität“. Koexistenz ≠ Komplementarität. Mehr Infos dazu: buff.ly/IyVOzVg
@secwatch.bsky.social🚨 JUST IN: $NAMS
European Commission approves obicetrapib (Ubeslo/Evlarco) for hypercholesterolaemia; first approval worldwide
#SEC #stocks #investing #NAMS #Regulatory
🔗 secwatch.observer
@mcphersoneri.bsky.socialDr. Bikash Pattnaik will be giving a special lecture for the Stem Cell & Regenerative Medicine Center on Tuesday, Sept. 22nd. His lecture will be available online through Zoom and in person in HSLC 1306 from 12 - 1 pm.
Link available here: buff.ly/jBwY3Pn
#StemCells, #PrecisionMedicine #RPE, #NAMs
@eara.euHow to use #SocialMedia to debunk #misinformation.
We went to the 62nd GV-SOLAS Annual Meeting, where Helena Pinheiro, EARA Communications & Social Media Officer, talked about #misinformation on #AnimalResearch and #NAMs online, and how #BOARD26 helped the #GermanResearch community push back.
@toxbox-project.bsky.social🍂 A new season, new steps for TOXBOX!
We are advancing an all-in-one platform for more reliable, human-relevant chemical toxicity testing.
🎥 Discover the project: www.youtube.com/watch?v=GXig...
Next: our consortium meeting in Slovenia!
@drainteo.bsky.socialIt’s my honour and pleasure to attend the Asia Organoid Consortium meeting organised by KoBIA. I shared on the R&D ecosystem in SG, efforts from SCSS, our annual Organoid Day, and efforts from A*STAR, IMCB, Cellular Engineering and Therapy (CET) Division.
#organoids #nams #scss #imcb #astar
@organoidchips.bsky.social
@risk-hunt3r.bsky.social#EUROTOX2026 is already underway!
Here’s a quick overview of the activities we’re taking part in — from #ASPIScluster & #RISK-HUNT3R sessions to poster contributions.
Join us to discuss the future of #animalfree #chemical #safetyassessment! Prgramme: www.eurotox2026.com/programme/
#NGRA #NAMs #H2020
@eara.eu#AnimalStudies remain essential to develop #cancer drugs 🔬
João Conde argues in a new #opinion piece that #organoids and other #NAMs can answer specific, localised questions, but can't yet replace #AnimalStudies for understanding #cancer drugs behave.
Learn more: 🔗 shorturl.at/Fh3Dc